Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Study of FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Patients With Advanced or Relapsed Gastric Cancer

NCT01138904 is registered in ClinicalTrials.gov with Dong-A University Hospital as lead sponsor.

NCT NCT01138904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01138904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Study of FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Patients With Advanced or Relapsed Gastric Cancer
Lead sponsor
Dong-A University Hospital
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
September 30, 2013
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer